The Elephant in the Waiting Room
I went to my annual physical last month expecting the usual lecture about my cholesterol numbers and whether I’ve been flossing like a functioning adult. Instead, somewhere between the blood pressure cuff and the discussion about my lower back pain, my doctor asked if I’d considered GLP-1 medications. Not in a pushy way. Just matter-of-fact, like she was asking if I’d updated my password recently.
I knew what she was talking about. You’d have to be living in a cave or working at a place with genuinely good WiFi blackouts to miss the conversation about these drugs. They’re everywhere right now. Your cousin at Thanksgiving might be on one. That influencer you follow is definitely on one. Apparently, somewhere around one in eight Americans has tried them, according to KFF GLP-1 medication tracking poll data, and that number feels like it’s climbing every week.
Why Everyone Lost Their Mind Over This
The numbers are genuinely wild. Prescriptions for these drugs jumped over 400% between 2022 and 2025. That’s not a gradual trend you missed. That’s a legitimate cultural moment, the kind that makes you realize something has actually shifted in how we approach weight and metabolism. Novo Nordisk’s Ozempic and Wegovy sales passed $25 billion combined, making these some of the most successful pharmaceutical products ever made. Full stop.
And here’s the thing that actually matters beyond the money: the science is real. Research published in the New England Journal of Medicine obesity research showed that tirzepatide produced an average weight loss of 22.5% of body weight over 72 weeks in adults with obesity. That’s not people losing ten pounds and feeling virtuous about it. That’s substantial, meaningful change. The American Medical Association updated its obesity treatment guidelines in 2025 to list these drugs as a first-line option alongside lifestyle changes. Six months ago this felt like a trend. Now it has institutional backing.
What My Doctor Actually Said (And Didn’t Say)
Here’s where I’m probably going to say something nobody wants to hear right now. My doctor didn’t oversell this. She didn’t hand me a prescription or act like this was a magic fix. She asked if I was interested, explained what it does, mentioned that insurance coverage is still a nightmare for a lot of people, and then moved on when I said I wanted to think about it. That restraint felt almost shocking in 2025.
She did acknowledge something that doesn’t get discussed enough in the viral TikToks about these drugs: cost and access are genuinely preventing people from using them. Of the people who’ve tried GLP-1 medications, 43% cite affordability as the reason they stopped. That’s not a small detail. That’s a majority of people who apparently couldn’t sustain access to something that was working for them. My doctor and I live in a world where the solution to a medical problem can be financially out of reach, and she didn’t shy away from naming that.
The Part Where I’m Probably Wrong
I’m skeptical of these drugs. Not of the science. The science is solid. I’m skeptical of the moment we’re in, where a weight loss medication becomes a status symbol and everyone’s talking about how their life is better because they’re not thinking about food anymore. That does something to a person, that kind of cultural fixation. It makes you wonder what we’re actually solving versus what we’re just medicalizing.
But I’m willing to be wrong about this. For people dealing with genuine metabolic dysfunction, for people where diet and exercise have been a Sisyphean nightmare for years, these drugs might actually be changing their relationship with food and their bodies in ways that matter. That’s not nothing. I’m also probably underestimating how many people are struggling in ways that aren’t visible to me.
So What Am I Actually Doing?
I’m thinking about it. Not diving in headfirst, but not dismissing it either. I’m trying to sit with the ambivalence of living in a time when pharmaceutical innovation is solving real problems and also getting wrapped up in the same capitalistic complexity that every medical advancement does. My doctor gave me space to figure out what matters to me specifically, which felt like the most helpful thing she could have done.
The conversation about GLP-1s isn’t really about the drugs themselves. It’s about how we talk about bodies, about metabolism, about what we’re supposed to do when the choices we’ve been told to make aren’t working the way we were promised they would. That conversation is worth having seriously, not just as a trend or a joke or a status thing.
What’s your experience been with all this? Have you considered these drugs? Tried them? Decided they weren’t for you? I’m genuinely curious how people are actually navigating this moment beyond what we’re seeing online.